Edition:
United States

Illumina Inc (ILMN.O)

ILMN.O on Nasdaq

175.91USD
26 May 2017
Change (% chg)

$2.15 (+1.24%)
Prev Close
$173.76
Open
$174.01
Day's High
$177.14
Day's Low
$173.80
Volume
959,273
Avg. Vol
992,591
52-wk High
$189.48
52-wk Low
$119.37

Select another date:

Tue, Apr 25 2017

BRIEF-Illumina reports Q1 GAAP earnings per share $2.52

* Illumina reports financial results for first quarter of fiscal year 2017

Illumina, Cornell drop gene sequencing patent dispute

Cornell University and biotechnology company Illumina Inc have dropped a lengthy patent dispute over gene-sequencing technology, citing a "settlement process."

BRIEF-Illumina Inc says CEO Francis A. Desouza's total 2016 compensation was $8.4 mln

* Illumina inc says ceo francis a. Desouza's total 2016 compensation was $8.4 million versus $5.4 million in 2015 - sec filing Source text - http://bit.ly/2ozO37O Further company coverage:

BRIEF-Illumina CEO Francis Desouza's FY 2016 total compensation was $8.4 mln - SEC Filing

* CEO Francis A. Desouza's FY 2016 total compensation was $8.4 million versus $5.4 million in FY 2015 - SEC Filing

BRIEF-Kailos genetics enters into a co-marketing agreement with Illumina

* Illumina will market and promote Kailos Targetrich line of research solutions for pharmacogenetics targets through commercial channels Source text for Eikon: Further company coverage:

Pharma groups file amicus brief in Illumina patent case

Trade groups representing the biotechnology and pharmaceutical industries have asked a federal appeals court to clarify the rules for determining whether arguments not put forth in U.S. Patent and Trademark Office proceedings can be raised later in district court.

BRIEF-Illumina says board increased size of board from 10 to 11 members

* On February 18, 2017, board increased size of board from ten to 11 members and elected John Thompson to board - SEC filing Source text (http://bit.ly/2m4NjYm) Further company coverage:

BRIEF-Illumina says Novaseq's S1, S4 flow cells expected to be available for shipment in Q3 2017

* Illumina Inc- Novaseq's S1 and S4 flow cells have been prioritized and are expected to be available for shipment in Q3 of 2017 - SEC filing

BRIEF-Illumina Q4 non-gaap earnings per share $0.85

* Illumina reports full financial results for fourth quarter and fiscal year 2016

BRIEF-Illumina elects Caroline Dorsa to serve on board

* Illumina Inc - effective as of Jan 26, 2017 increased size of board from nine to ten members and elected Caroline Dorsa to serve on board - SEC filing Source text: (http://bit.ly/2k1ulOq) Further company coverage:

Select another date:

More From Around the Web